Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI) Insider Trading
Directors, officers and holders of more than 10% of DNLI report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 102 transactions on file: 2 with code P, 11 with code S and 37 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Chin Peter Scott | Chief Medical Officer | S Sale | 1,654 | $22.29 | $36,868 |
| Sep 2, 2026 | Thornberry Nancy | Director | S Sale | 10,824 | $22.85 | $247,328 |
| Sep 2, 2026 | Thornberry Nancy | Director | S Sale | 615 | $23.74 | $14,600 |
| Sep 1, 2026 | Schuth Alexander O. | COFO and Secretary | S Sale | 2,768 | $23.44 | $64,882 |
| Aug 12, 2026 | Watts Ryan J. | President and CEO | G Gift | 32,220 | Not measured | Not measured |
| Aug 11, 2026 | Schuth Alexander O. | COFO and Secretary | S Sale | 2,857 | $25.07 | $71,625 |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Klein Peter S | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Van Hauwermeiren Timothy | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | FLATLEY JAY T | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | Thornberry Nancy | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Krognes Steve E. | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Van Hauwermeiren Timothy | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | FLATLEY JAY T | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Klein Peter S | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | Krognes Steve E. | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | Cook Jennifer E. | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | Schenkein David P | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Schenkein David P | Director | A Award | 6,408 | Not measured | Not measured |
| Jun 3, 2026 | Cook Jennifer E. | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | BAKER BROS. ADVISORS LP | Director | A Award | 19,226 | Not measured | Not measured |
| Jun 3, 2026 | Thornberry Nancy | Director | A Award | 6,408 | Not measured | Not measured |
| Jan 6, 2026 | Watts Ryan J. | President and CEO | S Sale | 35,198 | $16.50 | $580,767 |
| Jan 6, 2026 | Schuth Alexander O. | COFO and Secretary | S Sale | 17,218 | $16.50 | $284,097 |
| Jan 3, 2026 | Schuth Alexander O. | COFO and Secretary | A Award | 173,100 | Not measured | Not measured |
| Jan 3, 2026 | Watts Ryan J. | President and CEO | A Award | 236,880 | Not measured | Not measured |
| Jan 3, 2026 | Watts Ryan J. | President and CEO | A Award | 78,960 | Not measured | Not measured |
| Jan 3, 2026 | Schuth Alexander O. | COFO and Secretary | A Award | 57,700 | Not measured | Not measured |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Director | P Purchase | 190,523 | $17.49 | $3,332,247 |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Director | P Purchase | 2,095,191 | $17.49 | $36,644,891 |
| Nov 4, 2025 | Van Hauwermeiren Timothy | Director | A Award | 31,897 | Not measured | Not measured |
| Nov 4, 2025 | Van Hauwermeiren Timothy | Director | A Award | 10,632 | Not measured | Not measured |
| Sep 3, 2025 | Watts Ryan J. | President and CEO | G Gift | 50,000 | Not measured | Not measured |
| Aug 13, 2025 | Ho Carole | Chief Medical Officer | S Sale | 806 | $14.64 | $11,800 |
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | S Sale | 2,937 | $13.58 | $39,884 |
| Aug 12, 2025 | Ho Carole | Chief Medical Officer | S Sale | 2,937 | $13.58 | $39,884 |
| Aug 5, 2025 | Ho Carole | Chief Medical Officer | M Exercise | 44,655 | $0.6800 | $30,365 |
| Aug 5, 2025 | Ho Carole | Chief Medical Officer | M Exercise | 44,655 | Not measured | Not measured |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | M Exercise | 455,282 | Not measured | Not measured |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | M Exercise | 40,000 | $5.28 | $211,200 |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | M Exercise | 40,000 | Not measured | Not measured |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | M Exercise | 455,282 | $0.6800 | $309,592 |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | S Sale | 495,282 | $15.00 | $7,429,230 |
| Jun 3, 2025 | Tessier-Lavigne Marc | Director | A Award | 6,037 | Not measured | Not measured |
| Jun 3, 2025 | Schenkein David P | Director | A Award | 6,037 | Not measured | Not measured |
| Jun 3, 2025 | Klein Peter S | Director | A Award | 6,037 | Not measured | Not measured |
| Jun 3, 2025 | Klein Peter S | Director | A Award | 18,111 | Not measured | Not measured |
| Jun 3, 2025 | Tessier-Lavigne Marc | Director | A Award | 18,111 | Not measured | Not measured |
The full Form 4 history is on the DNLI company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.